Michael Enright has been appointed president of OckhamCRO, effective immediately. Mr. Enright will provide senior-level leadership and perspective to pharmaceutical, biotechnology and medical device clients for the company’s Phase I-IV clinical operations globally. He will also be responsible for driving overall corporate performance with a customer-centric focus. He has more than 15 years of experience in financial project management and surveying of the biotechnology and pharmaceutical mark...